Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in ...

DOJ is backing AbbVie in its battle to overturn a Colorado law that prohibits pharmaceutical companies from placing restrictions on the 340B drug discount program.

The provision, tucked into a sprawling bill, would allow UConn to add behavioral health beds without going through state ...

Claims by big hospital systems that the 340B Drug Pricing Program is “doing exactly what Congress intended” (“Comment: Hospitals staying true to Congress’ drug discounts,” The Herald, Feb. 14) ignore ...

Hospitals and clinics in Michigan participating in a federal drug discount program are marking up medications and shifting costs onto public employee health plans, according to ...

After The New York Times reported in 2022 that a national hospital chain with roots in Virginia had taken advantage of a federal drug pricing program called 340B, federal lawmakers assembled a ...

Feds back AbbVie Colorado 340B fight, arguing state law conflicts with federal 340B program in a key 10th Circuit appeal.

The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on ...

AstraZeneca Pharmaceuticals LP, for now, must abide by a Hawaii law that requires it to deliver discounted drugs to pharmacies contracted to serve low-income individuals.

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...